University of Kansas School of Medicine Clinical Neurophysiology

Topics

• Inflammatory Myopathies and Dermatomyositis 61
• Muscle Physiology and Disorders 61
• Amyotrophic Lateral Sclerosis Research 55
• Myasthenia Gravis and Thymoma 52
• Peripheral Neuropathies and Disorders 31
• Epilepsy research and treatment 25
• Genetic Neurodegenerative Diseases 22
• Pain Mechanisms and Treatments 16
• Lysosomal Storage Disorders Research 13
• Botulinum Toxin and Related Neurological Disorders 11
• Hereditary Neurological Disorders 11
• Neurological disorders and treatments 11

Most cited

1. Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study.

   The Lancet. Neurology · 2025 · 76 citations · Constantine Farmakidis

2. Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis.

   Frontiers in neurology · 2023 · 78 citations · Mamatha Pasnoor

3. Trial of Intravenous Immune Globulin in Dermatomyositis.

   The New England journal of medicine · 2022 · 163 citations · Mazen Dimachkie

4. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.

   JAMA · 2022 · 116 citations · Jeffrey Statland

5. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.

   The Lancet. Neurology · 2021 · 153 citations · Mazen Dimachkie

6. Source-sink connectivity: a novel interictal EEG marker for seizure localization.

   Brain : a journal of neurology · 2022 · 91 citations ·